Skip to main content
NCBI home page
PLOS Pathogens logoLink to PLOS Pathogens
. 2019 Mar 26;15(3):e1007646. doi: 10.1371/journal.ppat.1007646

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies

Celia C LaBranche, Andrew T McGuire, Matthew D Gray, Shay Behrens, Xuejun Chen, Tongqing Zhou, Quentin J Sattentau, James Peacock, Amanda Eaton, Kelli Greene, Hongmei Gao, Haili Tang, Lautaro G Perez, Kevin O Saunders, Peter D Kwong, John R Mascola, Barton F Haynes, Leonidas Stamatatos, David C Montefiori
PMCID: PMC6435110  PMID: 30913265

Peter D. Kwong and Xuejun Chen are not included in the author byline. Xuejun Chen should be listed as the fifth author and Peter D. Kwong should be listed as the fifteenth author. Both are affiliated with Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. The contributions of these authors are as follows: Investigation, Resources.

Reference

  • 1.LaBranche CC, McGuire AT, Gray MD, Behrens S, Zhou T, Sattentau QJ, et al. (2018) HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. PLoS Pathog 14(11): e1007431 10.1371/journal.ppat.1007431 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS Pathogens are provided here courtesy of PLOS

RESOURCES